Sign In

Login

Password

Forgot Password ? Sign Up

トリプタン (医薬品) (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "トリプタン (医薬品)" in Japanese language version.

refsWebsite
Global rank Japanese rank
6doi.org
2nd place
6th place
6nih.gov
4th place
24th place
1web.archive.org
1st place
1st place
1fda.gov
447th place
1,043rd place

doi.org

  • Tepper, S. J.; Rapoport, A. M.; Sheftell, F. D. (2002). “Mechanisms of action of the 5-HT1B/1D receptor agonists”. Archives of neurology 59 (7): 1084–1088. doi:10.1001/archneur.59.7.1084. PMID 12117355. 
  • Brandes JL, Kudrow D, Stark SR, et al. (2007). “Sumatriptan-naproxen for acute treatment of migraine: a randomized trial”. JAMA 297 (13): 1443–54. doi:10.1001/jama.297.13.1443. PMID 17405970. 
  • Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M (2000). “Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study”. Arch. Intern. Med. 160 (22): 3486–92. doi:10.1001/archinte.160.22.3486. PMID 11112243. 
  • Fuseau E, Petricoul O, Sabin A, et al. (2001). “Effect of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine”. Clinical therapeutics 23 (2): 242–51. doi:10.1016/S0149-2918(01)80006-0. PMID 11293557. 
  • Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D (2007). “Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability”. Headache 47 (8): 1152–68. doi:10.1111/j.1526-4610.2007.00849.x. PMID 17883520. 
  • Dahlöf CG, Mathew N (1998). “Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?”. Cephalalgia : an international journal of headache 18 (8): 539–45. doi:10.1046/j.1468-2982.1998.1808539.x. PMID 9827245. 

fda.gov

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Tepper, S. J.; Rapoport, A. M.; Sheftell, F. D. (2002). “Mechanisms of action of the 5-HT1B/1D receptor agonists”. Archives of neurology 59 (7): 1084–1088. doi:10.1001/archneur.59.7.1084. PMID 12117355. 
  • Brandes JL, Kudrow D, Stark SR, et al. (2007). “Sumatriptan-naproxen for acute treatment of migraine: a randomized trial”. JAMA 297 (13): 1443–54. doi:10.1001/jama.297.13.1443. PMID 17405970. 
  • Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M (2000). “Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study”. Arch. Intern. Med. 160 (22): 3486–92. doi:10.1001/archinte.160.22.3486. PMID 11112243. 
  • Fuseau E, Petricoul O, Sabin A, et al. (2001). “Effect of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine”. Clinical therapeutics 23 (2): 242–51. doi:10.1016/S0149-2918(01)80006-0. PMID 11293557. 
  • Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D (2007). “Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability”. Headache 47 (8): 1152–68. doi:10.1111/j.1526-4610.2007.00849.x. PMID 17883520. 
  • Dahlöf CG, Mathew N (1998). “Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?”. Cephalalgia : an international journal of headache 18 (8): 539–45. doi:10.1046/j.1468-2982.1998.1808539.x. PMID 9827245. 

web.archive.org